REPROS THERAPEUTICS INC.: cashflow_financing

Value{"amount": 11509000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2011-01-01 – 2011-03-31
Statuscurrent
EntityREPROS THERAPEUTICS INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001144204-12-029142 · Open the official SEC filing →
Retrieved: 2026-08-19T09:01:54.332042+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000897075/cashflow-financing/2011-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/26894e58-5de5-4a7f-989d-22ae35c3a246

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies